Hypoglycemia News and Research

RSS

Hypoglycemia, also called low blood glucose or low blood sugar, occurs when blood glucose drops below normal levels. Glucose, an important source of energy for the body, comes from food. Carbohydrates are the main dietary source of glucose.

Semaglutide reduces urine albumin-to-creatinine ratio in overweight chronic kidney disease patients

Researchers investigate the clinical efficacy of semaglutide in controlling urine albumin-to-creatinine ratio in overweight patients with chronic kidney disease.

31 Oct 2024

Study shows large language models susceptible to misinformation

Researchers reveal the vulnerability of large language models in medicine.

29 Oct 2024

New analysis confirms canagliflozin's cardiovascular and kidney benefits in older adults

Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2 diabetes, but it is unclear whether their effects differ based on patients' age.

26 Oct 2024

New glucose-sensitive insulin NNC2215 could transform diabetes care by lowering hypoglycemia risk

NNC2215, a glucose-sensitive insulin, offers improved glycemic control by dynamically adjusting to blood sugar levels, reducing hypoglycemia in diabetes care.

18 Oct 2024

Dietitians boost GLP-1 therapy success with personalized care and side effect management

Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients on GLP-1 medications for weight management. The study highlights the critical role of dietitians in guiding lifestyle and dietary changes.

15 Oct 2024

How carnitine transporters boost reproductive health

Research uncovers the critical role of carnitine transporters in maintaining fertility by regulating energy metabolism and protecting reproductive cells from oxidative stress. It suggests new pathways for treating infertility through carnitine supplementation and targeted therapies.

6 Oct 2024

Nanocapsules for glucagon offer a new approach to prevent hypoglycemia

People with diabetes take insulin to lower high blood sugar. However, if glucose levels plunge too low -; from taking too much insulin or not eating enough sugar -; people can experience hypoglycemia, which can lead to dizziness, cognitive impairment, seizures or comas.

2 Oct 2024

Why hypoglycemia-induced glucagon secretion becomes impaired in diabetes

Findings indicate that excessive somatostatin inhibits glucagon secretion in type 1 diabetes, offering a novel target for hypoglycemia management strategies.

27 Sep 2024

Tirzepatide outperforms insulin in controlling diabetes and promoting weight loss in clinical trials

Tirzepatide, a once-weekly dual agonist, outperforms long-acting insulin in reducing HbA1c, body weight, and improving cardiovascular markers in Type 2 diabetes patients.

2 Sep 2024

Tirzepatide beats semaglutide in lowering diabetes risk and cardiovascular events in obesity patients

A study published in eClinicalMedicine found that tirzepatide outperforms semaglutide in reducing the risk of type 2 diabetes and major cardiovascular events among individuals with obesity, with or without existing diabetes, while also achieving greater weight loss.

28 Aug 2024

Colorado's $100 copay cap improves diabetes medication adherence and health outcomes

Researchers examined the relationship between Colorado's $100 copayment maximum and self-expenditure, medication compliance, and health service usage for diabetes-associated comorbidities.

19 Aug 2024

New review highlights advances in diabetes research and treatment

A new paper surveying advances in diabetes pathogenesis and treatment explores the complex factors contributing to the onset and progression of the disease, suggesting that an understanding of these dynamics is key to developing targeted interventions to reduce the risk of developing diabetes and managing its complications.

25 Jul 2024

Long-term sulfonylurea use linked to increased risk of hypoglycemia unawareness

Sulfonylureas are a class of oral medications used to manage blood glucose levels in patients with type 2 diabetes.

22 Jul 2024

Innovative insulin algorithm enhances glucose control for hospitalized patients

Hospitalized patients with complex dietary restrictions often develop hyperglycemia, or high blood sugar.

25 Jun 2024

Intermittent fasting outperforms traditional drugs in managing early type 2 diabetes

Study shows that a 5:2 intermittent fasting meal replacement diet effectively controls blood glucose levels and reduces body weight in Chinese adults with early type 2 diabetes. This dietary intervention outperforms metformin and empagliflozin in managing diabetes and obesity.

24 Jun 2024

Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

Novo Nordisk today announced the presentation of 34 abstracts highlighting the breadth of its portfolio at the upcoming 84th Scientific Sessions of the American Diabetes Association (ADA).

22 Jun 2024

New antioxidant biomaterial may provide relief to people living with chronic pancreatitis

Northwestern University researchers have developed a new antioxidant biomaterial that someday could provide much-needed relief to people living with chronic pancreatitis.

7 Jun 2024

Ketones show promise in preventing cognitive decline and neurodegeneration

Researchers at the Del Monte Institute for Neuroscience at the University of Rochester have identified mechanisms in the brain's hippocampal network that are rescued by ketones.

31 May 2024

Understanding the impact of blood glucose levels on birth complications in gestational diabetes

The higher the blood sugar level in pregnant women when first diagnosed with diabetes, the higher the risk of complications around and after birth, according to research presented at the 26th European Congress of Endocrinology in Stockholm.

13 May 2024

Heightened risk of adverse neonatal outcomes from prenatal exposure to both cannabis and nicotine

A recent JAMA Network Open study found that combined prenatal use of nicotine and cannabis significantly increases risks for adverse perinatal outcomes, such as higher rates of hypertensive disease, preterm delivery, and elevated infant mortality compared to using neither or only one substance.

9 May 2024